• Home

  • Documents

  • mcl1.ncifcrf.govmcl1.ncifcrf.gov/dauter_pubs/025.pdf · Author: bnl [ HELIUM ] Created Date:...
5

mcl1.ncifcrf.govmcl1.ncifcrf.gov/dauter_pubs/025.pdf · Author: bnl [ HELIUM ] Created Date: 10/31/2002 11:22:29 AM

Embed Size (px)

Citation preview

Page 1: mcl1.ncifcrf.govmcl1.ncifcrf.gov/dauter_pubs/025.pdf · Author: bnl [ HELIUM ] Created Date: 10/31/2002 11:22:29 AM
Page 2: mcl1.ncifcrf.govmcl1.ncifcrf.gov/dauter_pubs/025.pdf · Author: bnl [ HELIUM ] Created Date: 10/31/2002 11:22:29 AM
Page 3: mcl1.ncifcrf.govmcl1.ncifcrf.gov/dauter_pubs/025.pdf · Author: bnl [ HELIUM ] Created Date: 10/31/2002 11:22:29 AM
Page 4: mcl1.ncifcrf.govmcl1.ncifcrf.gov/dauter_pubs/025.pdf · Author: bnl [ HELIUM ] Created Date: 10/31/2002 11:22:29 AM
Page 5: mcl1.ncifcrf.govmcl1.ncifcrf.gov/dauter_pubs/025.pdf · Author: bnl [ HELIUM ] Created Date: 10/31/2002 11:22:29 AM

A Novel Combination Treatment Targeting L and MCL1 for ... · Small Molecule Therapeutics A Novel Combination Treatment Targeting BCL-XL and MCL1 for KRAS/BRAF-mutated and BCL2L1-amplified

A Novel Combination Treatment Targeting L and MCL1 for ... · Small Molecule Therapeutics A Novel Combination Treatment Targeting BCL-XL and MCL1 for KRAS/BRAF-mutated and BCL2L1-amplified

Documents
Protein crystallography for non-crystallographers, …mcl1.ncifcrf.gov/dauter_pubs/269.pdfREVIEW ARTICLE Protein crystallography for non-crystallographers, or how to get the best (but

Protein crystallography for non-crystallographers, …mcl1.ncifcrf.gov/dauter_pubs/269.pdfREVIEW ARTICLE Protein crystallography for non-crystallographers, or how to get the best (but

Documents
CHAPTER 4: Research: Research Navigator and Avoiding Plagiarismwps.ablongman.com/wps/media/objects/1096/1122749/ir/MCL1... · 2004-06-02 · • Researching to fit the needs of different

CHAPTER 4: Research: Research Navigator and Avoiding Plagiarismwps.ablongman.com/wps/media/objects/1096/1122749/ir/MCL1... · 2004-06-02 · • Researching to fit the needs of different

Documents
Crystallisation and preliminary analysis of glucose ...mcl1.ncifcrf.gov/dauter_pubs/055.pdfisomerase from S. albus. These diffract to at least 1.6 A. The crystallisation and a preliminary

Crystallisation and preliminary analysis of glucose ...mcl1.ncifcrf.gov/dauter_pubs/055.pdfisomerase from S. albus. These diffract to at least 1.6 A. The crystallisation and a preliminary

Documents
Structure of Octreotide, a Somatostatin Analoguemcl1.ncifcrf.gov/dauter_pubs/109.pdf · a somatostatin analogue peptide. It provides a basis for further studies on the mechanism of

Structure of Octreotide, a Somatostatin Analoguemcl1.ncifcrf.gov/dauter_pubs/109.pdf · a somatostatin analogue peptide. It provides a basis for further studies on the mechanism of

Documents
Wireless Equipment Procurement Motorola e815 Wireless Team: Jeannie Hilderbrand 301-846-1716 - jhilderbrand@ncifcrf.govjhilderbrand@ncifcrf.gov Lori Smith

Wireless Equipment Procurement Motorola e815 Wireless Team: Jeannie Hilderbrand 301-846-1716 - [email protected]@ncifcrf.gov Lori Smith

Documents
* Citationscount J countTitle YearJournal DOI ublisherBubble/Eye … · 2020. 8. 12. · MCL1 gene silencing promotes senescence and apoptosis of glioma cells via inhibition of the

* Citationscount J countTitle YearJournal DOI ublisherBubble/Eye … · 2020. 8. 12. · MCL1 gene silencing promotes senescence and apoptosis of glioma cells via inhibition of the

Documents
l, A, A. - Macromolecular Crystallography Laboratory, …mcl1.ncifcrf.gov/dauter_pubs/085.pdf · John Long,O Sergey N. Berezhnoy,# Robert S. Phillips,’.x Emil H. Harutyunyan,s and

l, A, A. - Macromolecular Crystallography Laboratory, …mcl1.ncifcrf.gov/dauter_pubs/085.pdf · John Long,O Sergey N. Berezhnoy,# Robert S. Phillips,’.x Emil H. Harutyunyan,s and

Documents
StructureandFunctionalPropertiesoftheActiveFormofthe …mcl1.ncifcrf.gov/wlo_pubs/367.pdf · 2016-07-27 · of ComK, a transcriptional regulator involved in competence development,DNArepair,DNAtransformation,andrecombi-nation

StructureandFunctionalPropertiesoftheActiveFormofthe …mcl1.ncifcrf.gov/wlo_pubs/367.pdf · 2016-07-27 · of ComK, a transcriptional regulator involved in competence development,DNArepair,DNAtransformation,andrecombi-nation

Documents
Diffuse Large B Cell Lymphoma Cell Line U-2946: Model for MCL1 …1064625/... · 2017. 1. 12. · RESEARCH ARTICLE Diffuse Large B Cell Lymphoma Cell Line U-2946: Model for MCL1 Inhibitor

Diffuse Large B Cell Lymphoma Cell Line U-2946: Model for MCL1 …1064625/... · 2017. 1. 12. · RESEARCH ARTICLE Diffuse Large B Cell Lymphoma Cell Line U-2946: Model for MCL1 Inhibitor

Documents
Selection and characterization of Yersinia pestis YopN ...mcl1.ncifcrf.gov/waugh_pubs/9_Waugh.pdf · outer proteins (Yops) (Cornelis, 2000). Injectisomes are specialized protein-secretion

Selection and characterization of Yersinia pestis YopN ...mcl1.ncifcrf.gov/waugh_pubs/9_Waugh.pdf · outer proteins (Yops) (Cornelis, 2000). Injectisomes are specialized protein-secretion

Documents
Escherichia coli - mcl1.ncifcrf.gov

Escherichia coli - mcl1.ncifcrf.gov

Documents
The future of crystallography in drug discoverymcl1.ncifcrf.gov/wlo_pubs/343.pdfto recall that the structural model of a given protein or nucleic acid in the PDB is exactly that --

The future of crystallography in drug discoverymcl1.ncifcrf.gov/wlo_pubs/343.pdfto recall that the structural model of a given protein or nucleic acid in the PDB is exactly that --

Documents
3118 RESEARCH ARTICLE STEM CELLS AND REGENERATION · Mcl1 and NPC terminal mitosis RESEARCH ARTICLE 3119 targeted deletion of Mcl1 in adult NPCs in vivo resulted in a 3-fold increase

3118 RESEARCH ARTICLE STEM CELLS AND REGENERATION · Mcl1 and NPC terminal mitosis RESEARCH ARTICLE 3119 targeted deletion of Mcl1 in adult NPCs in vivo resulted in a 3-fold increase

Documents
Structural studies of algal lectins with anti-HIV activitymcl1.ncifcrf.gov/wlo_pubs/265.pdf · 2011. 6. 27. · Vol. 53 Algal lectins with anti-HIV activity 619 3ezm) is quite extended

Structural studies of algal lectins with anti-HIV activitymcl1.ncifcrf.gov/wlo_pubs/265.pdf · 2011. 6. 27. · Vol. 53 Algal lectins with anti-HIV activity 619 3ezm) is quite extended

Documents
Comparison of Different X-ray Data-Collection Systems …mcl1.ncifcrf.gov/dauter_pubs/110.pdfintensifier on an Enraf-Nonius FR571 rotating anode (Cu Ks radiation) was employed for

Comparison of Different X-ray Data-Collection Systems …mcl1.ncifcrf.gov/dauter_pubs/110.pdfintensifier on an Enraf-Nonius FR571 rotating anode (Cu Ks radiation) was employed for

Documents
RC1339/APRc from Rickettsia conoriiIs a Novel Aspartic ...mcl1.ncifcrf.gov/wlo_pubs/348.pdf · RC1339/APRc from Rickettsia conoriiIs a Novel Aspartic Protease with Properties of Retropepsin-Like

RC1339/APRc from Rickettsia conoriiIs a Novel Aspartic ...mcl1.ncifcrf.gov/wlo_pubs/348.pdf · RC1339/APRc from Rickettsia conoriiIs a Novel Aspartic Protease with Properties of Retropepsin-Like

Documents
Bis[3a,7a,12a-tris(4-nitrobenzoyloxy)-5b cholan-24-yl ...mcl1.ncifcrf.gov/dauter_pubs/286.pdf · Bortolini, O., Fantin, G. & Fogagnolo, M. (2010). Chirality, 22, 486–494. Davis,

Bis[3a,7a,12a-tris(4-nitrobenzoyloxy)-5b cholan-24-yl ...mcl1.ncifcrf.gov/dauter_pubs/286.pdf · Bortolini, O., Fantin, G. & Fogagnolo, M. (2010). Chirality, 22, 486–494. Davis,

Documents
research papers The structures of Micrococcus ...mcl1.ncifcrf.gov/dauter_pubs/211.pdf · 1974 Murshudov et al. Catalase Acta Cryst. (2002). D58, 1972–1982 2.2. Purification and

research papers The structures of Micrococcus ...mcl1.ncifcrf.gov/dauter_pubs/211.pdf · 1974 Murshudov et al. Catalase Acta Cryst. (2002). D58, 1972–1982 2.2. Purification and

Documents
Circadian Clock Gene CRY2 Degradation Is ... · prosurvival protein MCL1 levels and conferred resistance to Taxol-induced cell death, which indicated that FBXW7 is also involved in

Circadian Clock Gene CRY2 Degradation Is ... · prosurvival protein MCL1 levels and conferred resistance to Taxol-induced cell death, which indicated that FBXW7 is also involved in

Documents
Mechanisms of Allergen-Antibody Interaction of Cockroach ...mcl1.ncifcrf.gov/wlo_pubs/321.pdf · Background:Cockroach allergy is strongly associated with ... the contact PI of the

Mechanisms of Allergen-Antibody Interaction of Cockroach ...mcl1.ncifcrf.gov/wlo_pubs/321.pdf · Background:Cockroach allergy is strongly associated with ... the contact PI of the

Documents
MGMT-activated DUB3 stabilizes MCL1 and drives ...MGMT-activated DUB3 stabilizes MCL1 and drives chemoresistance in ovarian cancer Xiaowei Wua,1, Qingyu Luoa,1, Pengfei Zhaoa, Wan

MGMT-activated DUB3 stabilizes MCL1 and drives ...MGMT-activated DUB3 stabilizes MCL1 and drives chemoresistance in ovarian cancer Xiaowei Wua,1, Qingyu Luoa,1, Pengfei Zhaoa, Wan

Documents
Combining BH3-mimetics to target both BCL-2 and MCL1 has ... · dual BH3-mimetic approach is feasible, highly synergistic, and active in diverse models of human AML. This approach

Combining BH3-mimetics to target both BCL-2 and MCL1 has ... · dual BH3-mimetic approach is feasible, highly synergistic, and active in diverse models of human AML. This approach

Documents
Structure of the Taz2 domain of p300: insights into ligand ...mcl1.ncifcrf.gov/dauter_pubs/277.pdf · CBP-Taz2 (De Guzman et al., ... crystal structure of free Taz2 reported here,

Structure of the Taz2 domain of p300: insights into ligand ...mcl1.ncifcrf.gov/dauter_pubs/277.pdf · CBP-Taz2 (De Guzman et al., ... crystal structure of free Taz2 reported here,

Documents
Consensus Sequence Zen - ncifcrf.gov

Consensus Sequence Zen - ncifcrf.gov

Documents
Current Pharmaceutical Design, 3873-3884 3873 Structural ...mcl1.ncifcrf.gov/wlo_pubs/zdanov_04.pdf3874 Current Pharmaceutical Design, 2004, Vol. 10, No. 31 Alexander Zdanov IL-19

Current Pharmaceutical Design, 3873-3884 3873 Structural ...mcl1.ncifcrf.gov/wlo_pubs/zdanov_04.pdf3874 Current Pharmaceutical Design, 2004, Vol. 10, No. 31 Alexander Zdanov IL-19

Documents
research papers Structure of DraD invasin from ...mcl1.ncifcrf.gov/dauter_pubs/250.pdfCrystallography ISSN 0907-4449 Structure of DraD invasin from uropathogenic Escherichia coli:

research papers Structure of DraD invasin from ...mcl1.ncifcrf.gov/dauter_pubs/250.pdfCrystallography ISSN 0907-4449 Structure of DraD invasin from uropathogenic Escherichia coli:

Documents
Table S1 A collection of successful drug repositioning ... · 22 Wei G, Twomey D, Lamb J, et al. Gene expression-based chemical genomics identifies rapamycin as a modulator of MCL1

Table S1 A collection of successful drug repositioning ... · 22 Wei G, Twomey D, Lamb J, et al. Gene expression-based chemical genomics identifies rapamycin as a modulator of MCL1

Documents
P.F. Lemkin LECB, CCR, NCI/FCRDC mail: lemkin@ncifcrf.gov [This document is under construction] Revised: 06-19-2002 Software Design of the MicroArray Explorer

P.F. Lemkin LECB, CCR, NCI/FCRDC mail: [email protected] [This document is under construction] Revised: 06-19-2002 Software Design of the MicroArray Explorer

Documents
CCAAT/Enhancer-bindingProtein DNABindingIs Auto ...mcl1.ncifcrf.gov/wlo_pubs/millerm_11.pdf2 To whom correspondence should be addressed: Bldg. 539, Rm. 122, NCI-Frederick, National

CCAAT/Enhancer-bindingProtein DNABindingIs Auto ...mcl1.ncifcrf.gov/wlo_pubs/millerm_11.pdf2 To whom correspondence should be addressed: Bldg. 539, Rm. 122, NCI-Frederick, National

Documents